Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prelude Therapeutics (PRLD) Prepaid Assets (2024 - 2025)

Historic Prepaid Assets for Prelude Therapeutics (PRLD) over the last 2 years, with Q3 2025 value amounting to $3.4 million.

  • Prelude Therapeutics' Prepaid Assets rose 2216.59% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 2216.59%. This contributed to the annual value of $2.3 million for FY2024, which is N/A changed from last year.
  • Per Prelude Therapeutics' latest filing, its Prepaid Assets stood at $3.4 million for Q3 2025, which was up 2216.59% from $3.7 million recorded in Q2 2025.
  • Prelude Therapeutics' Prepaid Assets' 5-year high stood at $3.7 million during Q2 2025, with a 5-year trough of $2.3 million in Q4 2024.